ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1460

Neuropsychiatric Lupus in Late and Early Onset Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-analysis

Omer Pamuk1, Saja Ali2 and Sarfaraz Hasni2, 1NIH/NIAMS, Bethesda, MD, 2NIAMS/NIH, Bethesda, MD

Meeting: ACR Convergence 2022

Keywords: Aging, neuropsychiatric disorders, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: SLE – Diagnosis, Manifestations, and Outcomes Poster II: Manifestations

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: The diagnosis of neuropsychiatric lupus (NPSLE) is challenging due to its variegated presentation, absence of diagnostic biomarkers and radiological imaging. The NPSLE is further challenging in older patients due to increased likelihood of alternate explanation for the underlying symptoms. Objective: We performed a systematic review and meta-analysis to evaluate the frequency and differences in NPSLE manifestations in late-onset ( >50 years-old) SLE patients (ltSLE) as compared to adult-onset (17-50 years) (aSLE) and childhood-onset SLE (<16 years) (cSLE).

Methods: Literature search was performed using PubMed, Web of Science and Cochrane Library without any restrictions prior to May 2022. Studies were included fulfilled ACR 1997 revised classification criteria for SLE and ACR defined 1999 NPSLE syndromes. We excluded studies that did not include aSLE control group. Forest plot was used to compare odds ratios (95% CI) of NPSLE manifestations by age groups. Study heterogeneity was assessed using I2.

Results: Total of 43 studies with 17913 aSLE and 2982 ltSLE patients were included in the study. A total of 3331 patients had NPSLE (aSLE= 2861 and ltSLE= 368). NPSLE frequency was more common in aSLE compared to ltSLE (OR: 1.43, 95% CI: 1.26-1.62, p< 0.001) (Figure 1). The seizures (OR: 1.69, 95% CI: 1.29-2.19) and psychosis (OR: 2.70, 95% CI: 1.79-4.07) were more common in aSLE (p values < 0.001), whereas peripheral neuropathy was less prevalent in aSLE then ltSLE (OR: 0.69, 95% CI: 0.50-0.97, p=0.03) (Figure 2). 13/43 studies reported the rate of NPSLE at the time of initial presentation which was similar in aSLE and ltSLE at the time of diagnosis (OR: 1.19, 95%CI: 0.88-1.61). 14/43 studies reported data on cSLE. NPSLE rate was more common in cSLE compared to ltSLE (OR: 1.53, 95%: 1.16-2.01, p=0.0027) (Figure 3), but similar to aSLE group (OR: 0.96, 95%CI: 0.81-1.15, p >0.05).

Conclusion: The overall rates of NPSLE were less common in ltSLE as compared to aSLE and cSLE. Peripheral neuropathy was more frequent, but seizures and psychosis were less common presentation in ltSLE. At the time of initial disease presentation, the frequency of NPSLE was similar in ltSLE and aSLE.

Supporting image 1

Figure 1. Odd ratios of CNS disease in late-onset versus early-onset SLE patients.

Supporting image 2

Figure 2. Odd ratios of peripheral neuropathy in late-onset versus early-onset SLE patients.


Disclosures: O. Pamuk, None; S. Ali, None; S. Hasni, None.

To cite this abstract in AMA style:

Pamuk O, Ali S, Hasni S. Neuropsychiatric Lupus in Late and Early Onset Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-analysis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/neuropsychiatric-lupus-in-late-and-early-onset-systemic-lupus-erythematosus-patients-a-systemic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neuropsychiatric-lupus-in-late-and-early-onset-systemic-lupus-erythematosus-patients-a-systemic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology